Lessons from the ANTES B+ study
enero 14, 2026
Lessons from the ANTES B+ study highlighting challenges in COPD clinical trials, recruitment difficulties, and implications for future study design.
Lessons from the ANTES B+ study highlighting challenges in COPD clinical trials, recruitment difficulties, and implications for future study design.
Patients with COPD prioritise chronic symptoms and functional impact as key outcomes in COPD exacerbation treatment trials.
Early-stage lung immune infiltrate in idiopathic pulmonary fibrosis and its association with stable versus progressive disease in early IPF patients.
Review of the treatable traits approach in bronchiectasis, exploring phenotypes, endotypes, comorbidities, and its translation into clinical practice.
Study reveals systemic immune alterations in bronchiectasis patients with chronic Pseudomonas infection, highlighting persistent immune imbalance.
Conoce el estudio 3P que analiza los factores que predicen la progresión de la pre-EPOC a EPOC en fumadores con espirometría normal.
Participa en la Jornada RespirAP el 6 de mayo de 2026, un evento clave para impulsar un plan estratégico nacional en salud respiratoria. Formación, colaboración y acción.
Video de la presentación «Novedades GOLD 2026», en el que se trataron, entre otros aspectos: cambios en diagnóstico de la EPOC, tratamiento, comparativa con GESEPOC, etc.
This follow-up cohort study explores cardiac remodeling and reduced exercise tolerance in adolescents born small for gestational age, highlighting long-term cardiovascular implications.
Ocho investigadores del Clínic-IDIBAPS han sido reconocidos como Highly Cited Researchers 2025 por Clarivate Analytics, situándose entre los científicos más influyentes del mundo.